Error: Could not add to watchlist. X

Intercell AG

+ Watchlist
ICLL:AV
Acquired
ICLL:AV was acquired by VLA:FP
EUR
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (EUR) (TTM)
-0.49
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Intercell AG is a biotechnology company that develops vaccines for the prevention and treatment of infectious diseases. The Company has developed a vaccine to protect travelers from Japanese encephalitis.
ADDRESS
Campus Vienna Biocenter 3
Vienna, 1030
Austria
PHONE
43-1-20620
  • Thomas Lingelbach
    Chairman-Mgmt Board/CEO
  • Reinhard Kandera
    CFO/Member-Mgmt Board
Show More